lobbying_activities: 2060561
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2060561 | 7b5f62df-c48e-404f-875d-4251774889cc | Q4 | WAXMAN STRATEGIES | 401103693 | 340B HEALTH | 2017 | fourth_quarter | PHA | Issues affecting the 340B drug pricing program | HOUSE OF REPRESENTATIVES,SENATE | 18750 | 0 | 0 | 2018-01-11T15:41:03.830000-05:00 |